PCOS Is Now PMOS, And Experts Say It Marks A Turning Point In Women’s Health

Key Points:

• The condition formerly known as polycystic ovarian syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its complex hormonal and metabolic nature, moving away from the misleading focus on ovarian cysts.
• The renaming, led by Professor Helena Teede and international experts, aims to improve diagnosis, treatment, and long-term care by recognizing PMOS as a multisystem endocrine disorder rather than primarily a reproductive issue.
• The new definition empowers general practitioners to diagnose PMOS earlier and more accurately by considering a broader range of symptoms such as insulin resistance, acne, and menstrual irregularities, rather than relying heavily on ovarian imaging.
• Reclassifying the syndrome as PMOS highlights its association with increased risks of type 2 diabetes, cardiovascular disease, and mental health challenges, promoting earlier preventive care and ongoing monitoring throughout a woman's life.
• The global transition to the new terminology will continue through 2028, accompanied by international education campaigns to raise awareness among clinicians, patients, and policymakers.